{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T12:24:12Z","timestamp":1789302252748,"version":"build-2803163510"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03979-x","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T01:47:14Z","timestamp":1764208034000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Lactylation modification regulates acute myeloid leukemia pathogenesis and immune microenvironment"],"prefix":"10.1007","volume":"16","author":[{"given":"Ruixue","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guodong","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"issue":"1","key":"3979_CR1","first-page":"46","volume":"75","author":"HM Kantarjian","year":"2025","unstructured":"Kantarjian HM, DiNardo CD, Kadia TM, Daver NG, Altman JK, Stein EM, Ravandi F. Acute myeloid leukemia management and research in 2025. CA Cancer J Clin. 2025;75(1):46\u201367.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"3979_CR2","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/ajh.27625","volume":"100","author":"S Shimony","year":"2025","unstructured":"Shimony S, Stahl M, Stone RM. 2025 update on Diagnosis, Risk-Stratification, and management. Am J Hematol. 2025;100(5):860\u201391.","journal-title":"Am J Hematol"},{"issue":"12","key":"3979_CR3","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1182\/blood.2024024010","volume":"145","author":"GJ Roboz","year":"2025","unstructured":"Roboz GJ, Canaani J. How I use maintenance therapy in acute myeloid leukemia. Blood. 2025;145(12):1273\u201381.","journal-title":"Blood"},{"issue":"1","key":"3979_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13045-024-01571-4","volume":"17","author":"W Xiao","year":"2024","unstructured":"Xiao W, Nardi V, Stein E, Hasserjian RP. A practical approach on the classifications of myeloid neoplasms and acute leukemia: WHO and ICC. J Hematol Oncol. 2024;17(1):56.","journal-title":"J Hematol Oncol"},{"issue":"8","key":"3979_CR5","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1001\/jamaoncol.2024.0985","volume":"10","author":"LW Dillon","year":"2024","unstructured":"Dillon LW, Gui G, Ravindra N, Andrew G, Mukherjee D, Wong ZC, Hourigan CS. Measurable residual FLT3 internal tandem duplication before allogeneic transplant for acute myeloid leukemia. JAMA Oncol. 2024;10(8):1104\u201310.","journal-title":"JAMA Oncol"},{"issue":"3","key":"3979_CR6","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1182\/blood.2023022697","volume":"144","author":"CP Wienecke","year":"2024","unstructured":"Wienecke CP, Heida B, Venturini L, Gabdoulline R, Kr\u00fcger K, Teich K, Heuser M. Clonal relapse dynamics in acute myeloid leukemia following allogeneic hematopoietic cell transplantation. Blood. 2024;144(3):296\u2013307.","journal-title":"Blood"},{"issue":"11","key":"3979_CR7","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1182\/blood.2023021680","volume":"144","author":"F Mazziotta","year":"2024","unstructured":"Mazziotta F, Biavati L, Rimando J, Rutella S, Borcherding N, Parbhoo S, Luznik L. CD8\u2009+\u2009T-cell differentiation and dysfunction inform treatment response in acute myeloid leukemia. Blood. 2024;144(11):1168\u201382.","journal-title":"Blood"},{"issue":"7","key":"3979_CR8","doi-asserted-by":"publisher","first-page":"e35806","DOI":"10.1002\/cncr.35806","volume":"131","author":"J Senapati","year":"2025","unstructured":"Senapati J, Kadia TM, Daver NG, DiNardo CD, Borthakur G, Ravandi F, Kantarjian HM. Therapeutic horizon of acute myeloid leukemia: Success, optimism, and challenges. Cancer. 2025;131(7):e35806.","journal-title":"Cancer"},{"issue":"4","key":"3979_CR9","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1002\/ajh.27600","volume":"100","author":"EC Chen","year":"2025","unstructured":"Chen EC, Shimony S, Luskin MR, Stone RM. Biology and management of acute myeloid leukemia with mutated NPM1. Am J Hematol. 2025;100(4):652\u201365.","journal-title":"Am J Hematol"},{"key":"3979_CR10","doi-asserted-by":"publisher","first-page":"101224","DOI":"10.1016\/j.blre.2024.101224","volume":"68","author":"LS Williams","year":"2024","unstructured":"Williams LS, Nagaradona T, Nalamalapu P, Lai C. Breaking down frailty: assessing vulnerability in acute myeloid leukemia. Blood Rev. 2024;68:101224.","journal-title":"Blood Rev"},{"issue":"4","key":"3979_CR11","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1093\/jleuko\/qiae106","volume":"116","author":"Z Fang","year":"2024","unstructured":"Fang Z, Ding H, Han J, Fu L, Jin J, Feng W. Functions of N6-methyladenosine (m6A) RNA modifications in acute myeloid leukemia. J Leukoc Biol. 2024;116(4):662\u201371.","journal-title":"J Leukoc Biol"},{"key":"3979_CR12","doi-asserted-by":"crossref","unstructured":"Schurer A, Glushakow-Smith SG, Gritsman K. Targeting chromatin modifying complexes in acute myeloid leukemia. Stem Cells Transl Med, 2025. 14(2).","DOI":"10.1093\/stcltm\/szae089"},{"key":"3979_CR13","doi-asserted-by":"publisher","first-page":"104358","DOI":"10.1016\/j.critrevonc.2024.104358","volume":"198","author":"MG Della Porta","year":"2024","unstructured":"Della Porta MG, Martinelli G, Rambaldi A, Santoro A, Voso MT. A practical algorithm for acute myeloid leukaemia diagnosis following the updated 2022 classifications. Crit Rev Oncol Hematol. 2024;198:104358.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"6","key":"3979_CR14","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1182\/blood.2024026232","volume":"145","author":"G Huls","year":"2025","unstructured":"Huls G, Woolthuis CM, Schuringa JJ. Menin inhibitors in the treatment of acute myeloid leukemia. Blood. 2025;145(6):561\u20136.","journal-title":"Blood"},{"issue":"3","key":"3979_CR15","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1158\/2643-3230.BCD-24-0063","volume":"6","author":"N Ho","year":"2025","unstructured":"Ho N, Talvard-Balland N, K\u00f6hler N, Zeiser R. Immune escape of acute myeloid leukemia after transplantation. Blood Cancer Discov. 2025;6(3):168\u201381.","journal-title":"Blood Cancer Discov"},{"issue":"12","key":"3979_CR16","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1182\/blood.2024024011","volume":"145","author":"SD Green","year":"2025","unstructured":"Green SD, Wang ES. How I treat secondary acute myeloid leukemia. Blood. 2025;145(12):1260\u201372.","journal-title":"Blood"},{"issue":"6","key":"3979_CR17","doi-asserted-by":"publisher","first-page":"189214","DOI":"10.1016\/j.bbcan.2024.189214","volume":"1879","author":"BG de Santos","year":"2024","unstructured":"de Santos BG, Albuquerque de Melo M, Pereira-Martins DA, Machado-Neto JA, Traina F. An updated outlook on autophagy mechanism and how it supports acute myeloid leukemia maintenance. Biochim Biophys Acta Rev Cancer. 2024;1879(6):189214.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"22","key":"3979_CR18","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1097\/CM9.0000000000003195","volume":"137","author":"M Li","year":"2024","unstructured":"Li M, Zhao X. Leukocyte immunoglobulin-like receptor B4 (LILRB4) in acute myeloid leukemia: from prognostic biomarker to immunotherapeutic target. Chin Med J (Engl). 2024;137(22):2697\u2013711.","journal-title":"Chin Med J (Engl)"},{"key":"3979_CR19","doi-asserted-by":"crossref","unstructured":"Zhang X, Liu L, Senescent T, Cells. The silent culprit in acute myeloid leukemia progression? Int J Mol Sci, 2024. 25(23).","DOI":"10.3390\/ijms252312550"},{"key":"3979_CR20","doi-asserted-by":"crossref","unstructured":"Ahmed F, Zhong J. Advances in DNA\/RNA sequencing and their applications in acute myeloid leukemia (AML). Int J Mol Sci, 2024. 26(1).","DOI":"10.3390\/ijms26010071"},{"issue":"3","key":"3979_CR21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1158\/2643-3230.BCD-24-0140","volume":"6","author":"E Tin","year":"2025","unstructured":"Tin E, Rutella S, Khatri I, Na Y, Yan Y, MacLean N, Zhang L. SOCS1 protects acute myeloid leukemia against allogeneic T Cell-Mediated cytotoxicity. Blood Cancer Discov. 2025;6(3):217\u201332.","journal-title":"Blood Cancer Discov"},{"issue":"7","key":"3979_CR22","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1038\/s41375-021-01253-x","volume":"35","author":"N Daver","year":"2021","unstructured":"Daver N, Alotaibi AS, B\u00fccklein V, Subklewe M. T-cell-based immunotherapy of acute myeloid leukemia: current concepts and future developments. Leukemia. 2021;35(7):1843\u201363. https:\/\/doi.org\/10.1038\/s41375-021-01253-x.","journal-title":"Leukemia"},{"key":"3979_CR23","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1182\/blood-2019-127977","volume":"134","author":"M Subklewe","year":"2019","unstructured":"Subklewe M, Stein A, Walter RB, et al. Preliminary results from a phase 1 first-in-human study of AMG 673, a novel half-life extended (HLE) anti-CD33\/CD3 BiTE\u00ae(bispecific T-cell engager) in patients with relapsed\/refractory (R\/R) acute myeloid leukemia (AML)[J]. Blood. 2019;134:833.","journal-title":"Blood"},{"issue":"10","key":"3979_CR24","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.15537\/smj.2024.45.10.20240330","volume":"45","author":"A Almotiri","year":"2024","unstructured":"Almotiri A. CAR T-cell therapy in acute myeloid leukemia. Saudi Med J. 2024;45(10):1007\u201319. https:\/\/doi.org\/10.15537\/smj.2024.45.10.20240330.","journal-title":"Saudi Med J"},{"issue":"11","key":"3979_CR25","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1182\/blood.2024024063","volume":"145","author":"S Haubner","year":"2025","unstructured":"Haubner S, Subklewe M, Sadelain M. Honing CAR T cells to tackle acute myeloid leukemia. Blood. 2025;145(11):1113\u201325. https:\/\/doi.org\/10.1182\/blood.2024024063.","journal-title":"Blood"},{"issue":"1","key":"3979_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1182\/blood.2023022481","volume":"143","author":"F Thol","year":"2024","unstructured":"Thol F, D\u00f6hner H, Ganser A. How I treat refractory and relapsed acute myeloid leukemia. Blood. 2024;143(1):11\u201320. https:\/\/doi.org\/10.1182\/blood.2023022481.","journal-title":"Blood"},{"issue":"1","key":"3979_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s40164-025-00651-6","volume":"14","author":"H Zhang","year":"2025","unstructured":"Zhang H, Zhu HH. Breakthroughs of CAR T-cell therapy in acute myeloid leukemia: updates from ASH 2024. Exp Hematol Oncol. 2025;14(1):57. https:\/\/doi.org\/10.1186\/s40164-025-00651-6.","journal-title":"Exp Hematol Oncol"},{"issue":"4","key":"3979_CR28","doi-asserted-by":"publisher","first-page":"103471","DOI":"10.1016\/j.retram.2024.103471","volume":"72","author":"I Danylesko","year":"2024","unstructured":"Danylesko I, Shem-Tov N, Yerushalmi R, Jacoby E, Toren A, Shouval R, Itzhaki O, Avigdor A, Shimoni A, Nagler A. Point of care CD19 chimeric antigen receptor (CAR) T-cells for relapsed\/refractory acute myeloid leukemia (AML) with aberrant CD19 antigen expression. Curr Res Transl Med. 2024;72(4):103471. https:\/\/doi.org\/10.1016\/j.retram.2024.103471.","journal-title":"Curr Res Transl Med"},{"issue":"11","key":"3979_CR29","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.ccell.2024.09.006","volume":"42","author":"H Li","year":"2024","unstructured":"Li H, Sun L, Gao P, Hu H. Lactylation in cancer: current Understanding and challenges. Cancer Cell. 2024;42(11):1803\u20137.","journal-title":"Cancer Cell"},{"issue":"9","key":"3979_CR30","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1016\/j.cmet.2024.07.018","volume":"36","author":"L Yan","year":"2024","unstructured":"Yan L, Wang Y, Hu H, Yang D, Wang W, Luo Z, Zhang L. Physical exercise mediates cortical synaptic protein lactylation to improve stress resilience. Cell Metab. 2024;36(9):2104\u2013e21174.","journal-title":"Cell Metab"},{"issue":"1","key":"3979_CR31","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/brv.13135","volume":"100","author":"F Jing","year":"2025","unstructured":"Jing F, Zhang J, Zhang H, Li T. Unlocking the multifaceted molecular functions and diverse disease implications of lactylation. Biol Rev Camb Philos Soc. 2025;100(1):172\u201389.","journal-title":"Biol Rev Camb Philos Soc"},{"issue":"21","key":"3979_CR32","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1158\/0008-5472.CAN-23-3513","volume":"84","author":"C Zhang","year":"2024","unstructured":"Zhang C, Zhou L, Zhang M, Du Y, Li C, Ren H, Zheng L. H3K18 lactylation potentiates immune escape of Non-Small cell lung cancer. Cancer Res. 2024;84(21):3589\u2013601.","journal-title":"Cancer Res"},{"issue":"1","key":"3979_CR33","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13148-024-01682-2","volume":"16","author":"Y Hu","year":"2024","unstructured":"Hu Y, He Z, Li Z, Wang Y, Wu N, Sun H, Cong X. Lactylation: the novel histone modification influence on gene expression, protein function, and disease. Clin Epigenetics. 2024;16(1):72.","journal-title":"Clin Epigenetics"},{"issue":"8","key":"3979_CR34","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.tem.2024.01.011","volume":"35","author":"Z Yang","year":"2024","unstructured":"Yang Z, Zheng Y, Gao Q. Lysine lactylation in the regulation of tumor biology. Trends Endocrinol Metab. 2024;35(8):720\u201331.","journal-title":"Trends Endocrinol Metab"},{"issue":"28","key":"3979_CR35","doi-asserted-by":"publisher","first-page":"e2307216","DOI":"10.1002\/advs.202307216","volume":"11","author":"J Qiao","year":"2024","unstructured":"Qiao J, Tan Y, Liu H, Yang B, Zhang Q, Liu Q, Cui L. Histone H3K18 and Ezrin lactylation promote renal dysfunction in Sepsis-Associated acute kidney injury. Adv Sci (Weinh). 2024;11(28):e2307216.","journal-title":"Adv Sci (Weinh)"},{"issue":"8021","key":"3979_CR36","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41586-024-07620-9","volume":"631","author":"H Chen","year":"2024","unstructured":"Chen H, Li Y, Li H, Chen X, Fu H, Mao D, Zhang C. NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance. Nature. 2024;631(8021):663\u20139.","journal-title":"Nature"},{"key":"3979_CR37","doi-asserted-by":"publisher","first-page":"103194","DOI":"10.1016\/j.redox.2024.103194","volume":"74","author":"D Wu","year":"2024","unstructured":"Wu D, Spencer CB, Ortoga L, Zhang H, Miao C. Histone lactylation-regulated METTL3 promotes ferroptosis via m6A-modification on ACSL4 in sepsis-associated lung injury. Redox Biol. 2024;74:103194.","journal-title":"Redox Biol"},{"issue":"4","key":"3979_CR38","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.jhep.2024.04.010","volume":"81","author":"L Yang","year":"2024","unstructured":"Yang L, Niu K, Wang J, Shen W, Jiang R, Liu L, Tao K. Nucleolin lactylation contributes to intrahepatic cholangiocarcinoma pathogenesis via RNA splicing regulation of MADD. J Hepatol. 2024;81(4):651\u201366.","journal-title":"J Hepatol"},{"key":"3979_CR39","doi-asserted-by":"publisher","first-page":"155957","DOI":"10.1016\/j.metabol.2024.155957","volume":"158","author":"W Zhu","year":"2024","unstructured":"Zhu W, Guo S, Sun J, Zhao Y, Liu C. Lactate and lactylation in cardiovascular diseases: current progress and future perspectives. Metabolism. 2024;158:155957.","journal-title":"Metabolism"},{"issue":"11","key":"3979_CR40","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1038\/s41590-024-01985-9","volume":"25","author":"D Raychaudhuri","year":"2024","unstructured":"Raychaudhuri D, Singh P, Chakraborty B, Hennessey M, Tannir AJ, Byregowda S, Goswami S. Histone lactylation drives CD8(+) T cell metabolism and function. Nat Immunol. 2024;25(11):2140\u201351.","journal-title":"Nat Immunol"},{"key":"3979_CR41","doi-asserted-by":"crossref","unstructured":"Liu J, Zhao F, Qu Y. Lactylation: A novel Post-Translational modification with clinical implications in CNS diseases. Biomolecules, 2024. 14(9).","DOI":"10.3390\/biom14091175"},{"key":"3979_CR42","doi-asserted-by":"publisher","first-page":"116982","DOI":"10.1016\/j.biopha.2024.116982","volume":"177","author":"Y Li","year":"2024","unstructured":"Li Y, Cao Q, Hu Y, He B, Cao T, Tang Y, Liu SQ. Advances in the interaction of glycolytic reprogramming with lactylation. Biomed Pharmacother. 2024;177:116982.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"3979_CR43","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1038\/s41598-025-86136-2","volume":"15","author":"D Liu","year":"2025","unstructured":"Liu D, Liu S, Ji Y, Jin Z, He Z, Hou M, Ma X. Lactylation modulation identifies key biomarkers and therapeutic targets in KMT2A-rearranged AML. Sci Rep. 2025;15(1):1511.","journal-title":"Sci Rep"},{"issue":"1","key":"3979_CR44","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41392-023-01605-2","volume":"8","author":"ZW Huang","year":"2023","unstructured":"Huang ZW, Zhang XN, Zhang L, Liu LL, Zhang JW, Sun YX, Xu JQ, Liu Q, Long ZJ. STAT5 promotes PD-L1 expression by facilitating histone lactylation to drive immunosuppression in acute myeloid leukemia. Signal Transduct Target Ther. 2023;8(1):391. https:\/\/doi.org\/10.1038\/s41392-023-01605-2.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"3979_CR45","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41589-024-01680-8","volume":"21","author":"D Zhang","year":"2025","unstructured":"Zhang D, Gao J, Zhu Z, Mao Q, Xu Z, Singh PK, Rimayi CC, Moreno-Yruela C, Xu S, Li G, Sin YC, Chen Y, Olsen CA, Snyder NW, Dai L, Li L, Zhao Y. Lysine L-lactylation is the dominant lactylation isomer induced by Glycolysis. Nat Chem Biol. 2025;21(1):91\u20139. https:\/\/doi.org\/10.1038\/s41589-024-01680-8.","journal-title":"Nat Chem Biol"},{"issue":"3","key":"3979_CR46","doi-asserted-by":"publisher","first-page":"eabi6696","DOI":"10.1126\/sciadv.abi6696","volume":"8","author":"C Moreno-Yruela","year":"2022","unstructured":"Moreno-Yruela C, Zhang D, Wei W, B\u00e6k M, Liu W, Gao J, Dankov\u00e1 D, Nielsen AL, Bolding JE, Yang L, Jameson ST, Wong J, Olsen CA, Zhao Y. Class I histone deacetylases (HDAC1-3) are histone lysine delactylases. Sci Adv. 2022;8(3):eabi6696. https:\/\/doi.org\/10.1126\/sciadv.abi6696.","journal-title":"Sci Adv"},{"issue":"1","key":"3979_CR47","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1038\/s41467-024-47900-6","volume":"15","author":"Z Niu","year":"2024","unstructured":"Niu Z, Chen C, Wang S, Lu C, Wu Z, Wang A, Mo J, Zhang J, Han Y, Yuan Y, Zhang Y, Zang Y, He C, Bai X, Tian S, Zhai G, Wu X, Zhang K. HBO1 catalyzes lysine lactylation and mediates histone H3K9la to regulate gene transcription. Nat Commun. 2024;15(1):3561. https:\/\/doi.org\/10.1038\/s41467-024-47900-6.","journal-title":"Nat Commun"},{"issue":"8","key":"3979_CR48","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1158\/1078-0432.CCR-22-2263","volume":"29","author":"S Halford","year":"2023","unstructured":"Halford S, Veal GJ, Wedge SR, Payne GS, Bacon CM, Sloan P, Dragoni I, Heinzmann K, Potter S, Salisbury BM, Ch\u00e9nard-Poirier M, Greystoke A, Howell EC, Innes WA, Morris K, Plummer C, Rata M, Petrides G, Keun HC, Banerji U, Plummer R. A phase I Dose-escalation study of AZD3965, an oral monocarboxylate transporter 1 Inhibitor, in patients with advanced cancer. Clin Cancer Res. 2023;29(8):1429\u201339. https:\/\/doi.org\/10.1158\/1078-0432.CCR-22-2263.","journal-title":"Clin Cancer Res"},{"issue":"21","key":"3979_CR49","doi-asserted-by":"publisher","first-page":"6430","DOI":"10.1158\/1078-0432.CCR-17-1423","volume":"23","author":"CF Craddock","year":"2017","unstructured":"Craddock CF, Houlton AE, Quek LS, Ferguson P, Gbandi E, Roberts C, Metzner M, Garcia-Martin N, Kennedy A, Hamblin A, Raghavan M, Nagra S, Dudley L, Wheatley K, McMullin MF, Pillai SP, Kelly RJ, Siddique S, Dennis M, Cavenagh JD, Vyas P. Outcome of Azacitidine therapy in acute myeloid leukemia is not improved by concurrent Vorinostat therapy but is predicted by a diagnostic molecular signature. Clin Cancer Res. 2017;23(21):6430\u201340. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-1423.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"3979_CR50","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1007\/s10637-022-01235-5","volume":"40","author":"SF Powell","year":"2022","unstructured":"Powell SF, Mazurczak M, Dib EG, Bleeker JS, Geeraerts LH, Tinguely M, Lohr MM, McGraw SC, Jensen AW, Ellison CA, Black LJ, Puumala SE, Reed VJ, Miskimins WK, Lee JH, Spanos WC. Phase II study of dichloroacetate, an inhibitor of pyruvate dehydrogenase, in combination with chemoradiotherapy for unresected, locally advanced head and neck squamous cell carcinoma. Invest New Drugs. 2022;40(3):622\u201333. https:\/\/doi.org\/10.1007\/s10637-022-01235-5.","journal-title":"Invest New Drugs"},{"issue":"8","key":"3979_CR51","first-page":"2711","volume":"109","author":"DH Kim","year":"2024","unstructured":"Kim DH, Wang SA, Wang W, Tang G, Li S, Yin CC, Xu J. Acute myeloid leukemia with mast cell differentiation is characterized by interstitial mast cells, complex karyotype, TP53 alterations and poor prognosis. Haematologica. 2024;109(8):2711\u20135.","journal-title":"Haematologica"},{"issue":"11","key":"3979_CR52","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1007\/s11427-024-2666-8","volume":"67","author":"X Mo","year":"2024","unstructured":"Mo X, Zhang W, Fu G, Chang Y, Zhang X, Xu L, Huang X. Single-cell immune landscape of measurable residual disease in acute myeloid leukemia. Sci China Life Sci. 2024;67(11):2309\u201322.","journal-title":"Sci China Life Sci"},{"key":"3979_CR53","doi-asserted-by":"publisher","first-page":"108671","DOI":"10.1016\/j.pharmthera.2024.108671","volume":"259","author":"J Yang","year":"2024","unstructured":"Yang J, Liang F, Zhang F, Zhao H, Gong Q, Gao N. Recent advances in the reciprocal regulation of m(6)A modification with non-coding RNAs and its therapeutic application in acute myeloid leukemia. Pharmacol Ther. 2024;259:108671.","journal-title":"Pharmacol Ther"},{"key":"3979_CR54","doi-asserted-by":"publisher","first-page":"1505247","DOI":"10.3389\/fimmu.2025.1505247","volume":"16","author":"Y Wang","year":"2025","unstructured":"Wang Y, Yang X, Liu Y, Li Y. A review of common immunotherapy and nano immunotherapy for acute myeloid leukemia. Front Immunol. 2025;16:1505247.","journal-title":"Front Immunol"},{"issue":"20","key":"3979_CR55","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1158\/0008-5472.CAN-23-3560","volume":"84","author":"C Schneider","year":"2024","unstructured":"Schneider C, Spaink H, Alexe G, Dharia NV, Meyer A, Merickel LA. Stegmaier, targeting the Sodium-Potassium pump as a therapeutic strategy in acute myeloid leukemia. Cancer Res. 2024;84(20):3354\u201370.","journal-title":"Cancer Res"},{"key":"3979_CR56","doi-asserted-by":"publisher","first-page":"101173","DOI":"10.1016\/j.drup.2024.101173","volume":"78","author":"C Miao","year":"2025","unstructured":"Miao C, Huang Y, Zhang C, Wang X, Wang B, Zhou X, Feng Y. Post-translational modifications in drug resistance. Drug Resist Updat. 2025;78:101173.","journal-title":"Drug Resist Updat"},{"issue":"8","key":"3979_CR57","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41581-024-00837-x","volume":"20","author":"H Noels","year":"2024","unstructured":"Noels H, Jankowski V, Schunk SJ, Vanholder R, Kalim S, Jankowski J. Post-translational modifications in kidney diseases and associated cardiovascular risk. Nat Rev Nephrol. 2024;20(8):495\u2013512.","journal-title":"Nat Rev Nephrol"},{"issue":"46","key":"3979_CR58","doi-asserted-by":"publisher","first-page":"e2401399","DOI":"10.1002\/advs.202401399","volume":"11","author":"Y Lu","year":"2024","unstructured":"Lu Y, Zhu J, Zhang Y, Li W, Xiong Y, Fan Y, Zhang W. Lactylation-Driven IGF2BP3-Mediated Serine metabolism reprogramming and RNA m6A-Modification promotes lenvatinib resistance in HCC. Adv Sci (Weinh). 2024;11(46):e2401399.","journal-title":"Adv Sci (Weinh)"},{"issue":"4","key":"3979_CR59","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00395-024-01044-2","volume":"119","author":"GE Xu","year":"2024","unstructured":"Xu GE, Yu P, Hu Y, Wan W, Shen K, Cui X, Xiao J. Exercise training decreases lactylation and prevents myocardial ischemia-reperfusion injury by inhibiting YTHDF2. Basic Res Cardiol. 2024;119(4):651\u201371.","journal-title":"Basic Res Cardiol"},{"key":"3979_CR60","doi-asserted-by":"publisher","first-page":"102102","DOI":"10.1016\/j.tranon.2024.102102","volume":"49","author":"M Zhu","year":"2024","unstructured":"Zhu M, Xiao Q, Cai X, Chen Z, Shi Q, Sun X, Xie X, Sun M. Predicting lymphoma prognosis using machine learning-based genes associated with lactylation. Transl Oncol. 2024;49:102102. https:\/\/doi.org\/10.1016\/j.tranon.2024.102102.","journal-title":"Transl Oncol"},{"issue":"7779","key":"3979_CR61","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, Liu W, Kim S, Lee S, Perez-Neut M, Ding J, Czyz D, Hu R, Ye Z, He M, Zheng YG, Shuman HA, Dai L, Ren B, Roeder RG, Becker L, Zhao Y. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574(7779):575\u201380. https:\/\/doi.org\/10.1038\/s41586-019-1678-1.","journal-title":"Nature"},{"issue":"8021","key":"3979_CR62","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41586-024-07620-9","volume":"631","author":"H Chen","year":"2024","unstructured":"Chen H, Li Y, Li H, Chen X, Fu H, Mao D, Chen W, Lan L, Wang C, Hu K, Li J, Zhu C, Evans I, Cheung E, Lu D, He Y, Behrens A, Yin D, Zhang C. NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance. Nature. 2024;631(8021):663\u20139. https:\/\/doi.org\/10.1038\/s41586-024-07620-9.","journal-title":"Nature"},{"issue":"1","key":"3979_CR63","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1038\/s41598-025-86136-2","volume":"15","author":"D Liu","year":"2025","unstructured":"Liu D, Liu S, Ji Y, Jin Z, He Z, Hou M, Li D, Ma X. Lactylation modulation identifies key biomarkers and therapeutic targets in KMT2A-rearranged AML. Sci Rep. 2025;15(1):1511. https:\/\/doi.org\/10.1038\/s41598-025-86136-2.","journal-title":"Sci Rep"},{"issue":"11","key":"3979_CR64","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1038\/s41590-024-01985-9","volume":"25","author":"D Raychaudhuri","year":"2024","unstructured":"Raychaudhuri D, Singh P, Chakraborty B, Hennessey M, Tannir AJ, Byregowda S, Natarajan SM, Trujillo-Ocampo A, Im JS, Goswami S. Histone lactylation drives CD8\u2009+\u2009T cell metabolism and function. Nat Immunol. 2024;25(11):2140\u201351. https:\/\/doi.org\/10.1038\/s41590-024-01985-9.","journal-title":"Nat Immunol"},{"issue":"11","key":"3979_CR65","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1002\/cac2.12607","volume":"44","author":"J Cai","year":"2024","unstructured":"Cai J, Song L, Zhang F, Wu S, Zhu G, Zhang P, Dai Z. Targeting SRSF10 might inhibit M2 macrophage polarization and potentiate anti-PD-1 therapy in hepatocellular carcinoma. Cancer Commun (Lond). 2024;44(11):1231\u201360.","journal-title":"Cancer Commun (Lond)"},{"key":"3979_CR66","doi-asserted-by":"publisher","first-page":"111228","DOI":"10.1016\/j.cellsig.2024.111228","volume":"120","author":"F Song","year":"2024","unstructured":"Song F, Hou C, Huang Y, Liang J, Cai H, Tian G, Hou J. Lactylome analyses suggest systematic lysine-lactylated substrates in oral squamous cell carcinoma under normoxia and hypoxia. Cell Signal. 2024;120:111228.","journal-title":"Cell Signal"},{"issue":"4","key":"3979_CR67","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41418-024-01423-1","volume":"32","author":"Y Liu","year":"2025","unstructured":"Liu Y, Liu P, Duan S, Lin J, Qi W, Yu Z, Shen B. CTCF enhances pancreatic cancer progression via FLG-AS1-dependent epigenetic regulation and macrophage polarization. Cell Death Differ. 2025;32(4):745\u201362.","journal-title":"Cell Death Differ"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03979-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03979-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03979-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T03:02:41Z","timestamp":1767063761000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03979-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3979"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03979-x","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"1 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All authors have read and approved the final version. No conflicts of interest are declared. This manuscript is original, has not been published elsewhere, and is not under consideration by any other journal. All data are derived from publicly accessible repositories; no human subjects or animal experiments were conducted.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publishcation"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2320"}}